Business Context and Reporting Period
This Form 8-K, filed on June 22, 2014, by Oracle Corporation (Oracle), announces the entry into an Agreement and Plan of Merger to acquire MICROS Systems, Inc. (MICROS). The transaction involves a cash tender offer followed by a merger, with the agreement dated June 22, 2014.
Key Financial Metrics and Transaction Terms
- Purchase Price: $68.00 per share in cash, net to holders, without interest.
- Termination Fee: Approximately $157.78 million payable by MICROS to Oracle under certain customary circumstances.
- Transaction Structure: A cash tender offer by a wholly-owned subsidiary (Rocket Acquisition Corporation) followed by a merger where MICROS becomes the surviving corporation.
- Compensatory Awards: Unvested options for employees/consultants will be assumed and converted to Oracle stock options. Vested options and awards held by non-employees will be cancelled for cash equal to the spread between the offer price and exercise price.
Note: This filing does not provide Oracle's or MICROS's standalone revenue, profit, cash flow, or debt metrics. It focuses exclusively on the terms of the acquisition agreement.
Material Changes and Conditions
The filing details the conditions required for the consummation of the offer, including:
- Receipt of a majority of MICROS common stock (on a fully diluted basis) validly tendered and not withdrawn.
- Receipt of regulatory approvals, including the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and applicable European Commission merger control laws.
- Accuracy of representations and warranties and compliance with covenants in the Merger Agreement.
MICROS has agreed not to solicit alternative acquisition proposals, subject to customary fiduciary exceptions.
Outlook, Management Commentary, and Risks
The Board of Directors of MICROS has unanimously approved the Merger Agreement and recommended that stockholders accept the tender offer. Oracle has agreed to assume the liabilities and obligations of its acquisition subsidiaries under the agreement. The tender offer is expected to commence promptly, but no later than ten business days from the agreement date.
Risks and Contingencies: The transaction is subject to regulatory approval and the tendering of a majority of shares. The filing explicitly states that the Merger Agreement is not intended to modify or supplement factual disclosures in other public reports and that representations may be subject to different materiality standards.
Investor Verification Checklist
- Verify the commencement date of the tender offer (expected within 10 business days of June 22, 2014).
- Review the upcoming Schedule TO (Offer to Purchase) and Schedule 14D-9 (Solicitation/Recommendation Statement) for detailed financial data and risk factors.
- Monitor regulatory approval status, specifically regarding the Hart-Scott-Rodino Act and European Commission merger control laws.
- Confirm the treatment of specific stock options and compensatory awards if holding MICROS equity or options.